Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon amplifies complement activation by Burkitt's lymphoma cells.

E Yefenof, I McConnell

    Nature
    |February 21, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    One Health in the context of medical and veterinary education.

    Revue scientifique et technique (International Office of Epizootics)·2015
    Same author

    E-cadherin expression in canine cutaneous histiocytomas.

    The Veterinary record·2008
    Same author

    Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome.

    Archives of oral biology·2007
    Same author

    Cloning and sequencing of ovine Flt3 ligand.

    International journal of immunogenetics·2007
    Same author

    Salivary LL-37 secretion in individuals with Down syndrome is normal.

    Journal of dental research·2006
    Same author

    The outcome of a preventive dental care programme on the prevalence of localized aggressive periodontitis in Down's syndrome individuals.

    Journal of intellectual disability research : JIDR·2006
    Same journal

    Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

    Nature·2026
    Same journal

    China boosts prestigious grants for young scientists - will it ease competition?

    Nature·2026
    Same journal

    Incoming US science academy chief vows to 'double down' on research.

    Nature·2026
    Same journal

    Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

    Nature·2026
    Same journal

    Electrodeposited self-assembled molecules for perovskite photovoltaics.

    Nature·2026
    Same journal

    Neutrino's nursery found: the 'Shadow Blaster'.

    Nature·2026
    See all related articles

    Interferon, initially known for antiviral effects, also impacts cell division and immune responses. This study shows interferon enhances tumor cells' ability to activate complement, suggesting a role in anti-tumor immunity.

    Area of Science:

    • Immunology
    • Virology
    • Cell Biology

    Background:

    • Interferon (IFN) is a key antiviral agent with diverse immune-modulating functions.
    • IFNs inhibit cell division, upregulate cell-surface antigens, and enhance natural killer (NK) cell activity.
    • Immune interferon (IFN-gamma) is produced by T cells and plays a role in adaptive immunity.

    Purpose of the Study:

    • To investigate the role of interferon in modulating tumor cell interactions with the immune system.
    • To explore potential novel functions of interferon beyond its known antiviral and immune-stimulating activities.

    Main Methods:

    • Utilized monoclonal antibody-purified interferon for experimental manipulation.
    • Assessed the activation of the alternative pathway of complement by tumor cells.

    Related Experiment Videos

  • Quantified the effect of interferon on complement activation in specific tumor cell lines.

    • Main Results:

    • Interferon was shown to amplify the complement-activating ability of certain tumor cells via the alternative pathway.
    • This effect was observed in specific human lymphoma and tumor cell types.
    • The findings suggest interferon can influence non-specific anti-tumor immunity.

    Conclusions:

    • Interferon possesses a previously unrecognized function in enhancing tumor cell complement activation.
    • This mechanism may contribute to non-specific anti-tumor immunity.
    • Further research is warranted to elucidate the full implications of interferon in cancer immunology.